Fact CheckerSign in

NCT07753343Recruiting

Identification and Description of Patients With High-risk Non Metastatic RCC

Identification and Description of Patients With High-risk Non Metastatic RCC (UroCCR 127)

Source: ClinicalTrials.gov · Last updated 7 Aug 2026

Brief summary (registry, in English)

Renal cell carcinoma (RCC) is the 14th most common cancer worldwide. Surgery is the standard of care for localized RCC, however, the risk of recurrence varies widely among patients. Adjuvant pembrolizumab has been shown to improve outcomes after nephrectomy but is associated with substantial toxicity and high costs. This study uses real-world data from the French UroCCR-Chain registry to characterize the natural history, management, and outcomes of non-metastatic RCC in France, with the aim of informing adjuvant treatment decisions

Status (registry)
Recruiting
Study type
Observational
Enrollment
6109 (estimated)
First submitted
20 Jul 2026
Start date
17 Apr 2026
Primary completion date
17 Apr 2028
Lead sponsor
University Hospital, Bordeaux
NCT number
NCT07753343

What you commit to

  • Study type: Observational
  • Planned participants: 6109
  • From 17 Apr 2026 to the primary completion date, 17 Apr 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with metastatic disease at inclusion,

Other

  • Patients not linked between UroCCR and SNDS datasources,
  • Patients with hereditary RCC.

Who the study is looking for

  • Adult patients diagnosed with local RCC or high-risk locally advanced RCC,
  • Included in UroCCR register between 1st january 2014 and 31st december 2023,
  • Consenting to participate in UroCCR and UroCCR-Chain registers.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU Bordeaux
Coordinator of this site? Confirm its status
BordeauxFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.